MiRNA: A Promising Therapeutic Target in Cancer

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Oct 14

PMID 36232799

Authors

Amrutha Menon

Noraini Abd-Aziz

Kanwal Khalid

Chit Laa Poh

Rakesh Naidu

Affiliations

Soon will be listed here.

Abstract

microRNAs are small non-coding RNAs that regulate several genes post-transcriptionally by complementarity pairing. Since discovery, they have been reported to be involved in a variety of biological functions and pathologies including cancer. In cancer, they can act as a tumor suppressor or oncomiR depending on the cell type. Studies have shown that miRNA-based therapy, either by inhibiting an oncomiR or by inducing a tumor suppressor, is effective in cancer treatment. This review focusses on the role of miRNA in cancer, therapeutic approaches with miRNAs and how they can be effectively delivered into a system. We have also summarized the patents and clinical trials in progress for miRNA therapy.

Citing Articles

Engineered exosomes restore miR-508-5p expression in uterine corpus endometrial carcinoma and reduce tumor progression and metastasis by targeting DLL3.

Li Y, Liu H, Feng J, Tian W, Du J, Zhang L Front Oncol. 2025; 15:1532564.

PMID: 40066092 PMC: 11891050. DOI: 10.3389/fonc.2025.1532564.

Exploring miR-21 Knock-Out Using CRISPR/Cas as a Treatment for Lung Cancer.

Lara P, Aguilar-Gonzalez A, Martin F, Mesas C, Moreno J, Rama A Genes (Basel). 2025; 16(2).

PMID: 40004462 PMC: 11855122. DOI: 10.3390/genes16020133.

Non-Coding RNAs in Cancer: Structure, Function, and Clinical Application.

Marton E, Varga A, Domoszlai D, Buglyo G, Balazs A, Penyige A Cancers (Basel). 2025; 17(4).

PMID: 40002172 PMC: 11853212. DOI: 10.3390/cancers17040579.

[Predictive Value of A miRNA Signature for Distant Metastasis in Lung Cancer].

Cong J, Wang A, Wang Y, Li X, Pi J, Liu K Zhongguo Fei Ai Za Zhi. 2025; 27(12):919-930.

PMID: 39962847 PMC: 11839496. DOI: 10.3779/j.issn.1009-3419.2024.102.43.

miR-455-3p has superior diagnostic potential to PSA in peripheral blood for prostate cancer.

Cen Y, Feng S, Xu Y, Zhang C, Lin X, Ye X PLoS One. 2025; 20(2):e0317385.

PMID: 39951446 PMC: 11828392. DOI: 10.1371/journal.pone.0317385.

References

Yang C, Hung P, Wang P, Liu C, Chu T, Cheng H . miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma. J Oral Pathol Med. 2011; 40(5):397-404. DOI: 10.1111/j.1600-0714.2010.01003.x. View

Orom U, Nielsen F, Lund A . MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell. 2008; 30(4):460-71. DOI: 10.1016/j.molcel.2008.05.001. View

Shi S, Han L, Deng L, Zhang Y, Shen H, Gong T . Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression. J Control Release. 2014; 194:228-37. DOI: 10.1016/j.jconrel.2014.09.005. View

Hong D, Kang Y, Borad M, Sachdev J, Ejadi S, Lim H . Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer. 2020; 122(11):1630-1637. PMC: 7251107. DOI: 10.1038/s41416-020-0802-1. View

Watashi K, Yeung M, Starost M, Hosmane R, Jeang K . Identification of small molecules that suppress microRNA function and reverse tumorigenesis. J Biol Chem. 2010; 285(32):24707-16. PMC: 2915707. DOI: 10.1074/jbc.M109.062976. View

Hei Y, Wang S, Xi X, Wang H, Guo Y, Xin M . Design, synthesis, and evaluation of fluoroquinolone derivatives as microRNA-21 small-molecule inhibitors. J Pharm Anal. 2022; 12(4):653-663. PMC: 9463491. DOI: 10.1016/j.jpha.2021.12.008. View

Tao K, Yang J, Guo Z, Hu Y, Sheng H, Gao H . Prognostic value of miR-221-3p, miR-342-3p and miR-491-5p expression in colon cancer. Am J Transl Res. 2014; 6(4):391-401. PMC: 4113501. View

Cimmino A, Calin G, Fabbri M, Iorio M, Ferracin M, Shimizu M . miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005; 102(39):13944-9. PMC: 1236577. DOI: 10.1073/pnas.0506654102. View

Xiao C, Calado D, Galler G, Thai T, Patterson H, Wang J . MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell. 2007; 131(1):146-59. DOI: 10.1016/j.cell.2007.07.021. View

10.

Nieuweboer A, de Morree E, de Graan A, Sparreboom A, de Wit R, Mathijssen R . Inter-patient variability in docetaxel pharmacokinetics: A review. Cancer Treat Rev. 2015; 41(7):605-13. DOI: 10.1016/j.ctrv.2015.04.012. View

11.

Toki T, Katsuoka F, Kanezaki R, Xu G, Kurotaki H, Sun J . Transgenic expression of BACH1 transcription factor results in megakaryocytic impairment. Blood. 2004; 105(8):3100-8. DOI: 10.1182/blood-2004-07-2826. View

12.

Lim K, Maruyama R, Yokota T . Eteplirsen in the treatment of Duchenne muscular dystrophy. Drug Des Devel Ther. 2017; 11:533-545. PMC: 5338848. DOI: 10.2147/DDDT.S97635. View

13.

Carthew R, Sontheimer E . Origins and Mechanisms of miRNAs and siRNAs. Cell. 2009; 136(4):642-55. PMC: 2675692. DOI: 10.1016/j.cell.2009.01.035. View

14.

Kabekkodu S, Shukla V, Varghese V, D Souza J, Chakrabarty S, Satyamoorthy K . Clustered miRNAs and their role in biological functions and diseases. Biol Rev Camb Philos Soc. 2018; 93(4):1955-1986. DOI: 10.1111/brv.12428. View

15.

Craig V, Tzankov A, Flori M, Schmid C, Bader A, Muller A . Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo. Leukemia. 2012; 26(11):2421-4. DOI: 10.1038/leu.2012.110. View

16.

Park J, Shin C . MicroRNA-directed cleavage of targets: mechanism and experimental approaches. BMB Rep. 2014; 47(8):417-23. PMC: 4206712. DOI: 10.5483/bmbrep.2014.47.8.109. View

17.

Sicard F, Gayral M, Lulka H, Buscail L, Cordelier P . Targeting miR-21 for the therapy of pancreatic cancer. Mol Ther. 2013; 21(5):986-94. PMC: 3666633. DOI: 10.1038/mt.2013.35. View

18.

Hermeking H . The miR-34 family in cancer and apoptosis. Cell Death Differ. 2009; 17(2):193-9. DOI: 10.1038/cdd.2009.56. View

19.

Crew E, Tessel M, Rahman S, Razzak-Jaffar A, Mott D, Kamundi M . MicroRNA conjugated gold nanoparticles and cell transfection. Anal Chem. 2011; 84(1):26-9. DOI: 10.1021/ac202749p. View

20.

Lodish H, Zhou B, Liu G, Chen C . Micromanagement of the immune system by microRNAs. Nat Rev Immunol. 2008; 8(2):120-30. DOI: 10.1038/nri2252. View